keyword
https://read.qxmd.com/read/38634650/muscarinic-receptors-in-cardioprotection-and-vascular-tone-regulation
#1
JOURNAL ARTICLE
E Dolejší, A Janoušková, J Jakubík
Muscarinic acetylcholine receptors are metabotropic G-protein coupled receptors. Muscarinic receptors in the cardiovascular system play a central role in its regulation. Particularly M2 receptors slow down the heart rate by reducing the impulse conductivity through the atrioventricular node. In general, activation of muscarinic receptors has sedative effects on the cardiovascular system, including vasodilation, negative chronotropic and inotropic effects on the heart, and cardioprotective effects, including antifibrillatory effects...
April 18, 2024: Physiological Research
https://read.qxmd.com/read/38632204/a-systematic-review-of-the-impact-of-simulation-on-students-confidence-in-performing-clinical-pharmacy-activities
#2
REVIEW
Jean-François Huon, Pierre Nizet, Sophie Tollec, Elise Vene, Clémentine Fronteau, Alison Leichnam, Martine Tching-Sin, Vanessa Michelet-Barbotin, Laura Foucault-Fruchard, Fabien Nativel
BACKGROUND: Although confidence does not automatically imply competence, it does provide pharmacy students with a sense of empowerment to manage a pharmacotherapeutic problem independently. Among the methods used in higher education, there is growing interest in simulation. AIM: To evaluate the impact of simulation on pharmacy students' confidence in performing clinical pharmacy activities. METHOD: Articles that reported the use of simulation among pharmacy students with fully described outcomes about confidence were included...
April 17, 2024: International Journal of Clinical Pharmacy
https://read.qxmd.com/read/38622054/pharmacotherapeutic-strategies-for-friedreich-ataxia-a-review-of-the-available-data
#3
REVIEW
Katherine Gunther, David R Lynch
INTRODUCTION: Friedreich ataxia (FRDA) is a rare autosomal recessive disease, marked by loss of coordination as well as impaired neurological, endocrine, orthopedic, and cardiac function. There are many symptomatic medications for FRDA, and many clinical trials have been performed, but only one FDA-approved medication exists. AREAS COVERED: The relative absence of the frataxin protein (FXN) in FRDA causes mitochondrial dysfunction, resulting in clinical manifestations...
April 15, 2024: Expert Opinion on Pharmacotherapy
https://read.qxmd.com/read/38612466/unveiling-anti-diabetic-potential-of-baicalin-and-baicalein-from-baikal-skullcap-lc-ms-in-silico-and-in-vitro-studies
#4
JOURNAL ARTICLE
Wencheng Zhao, Huizi Cui, Kaifeng Liu, Xiaotang Yang, Shu Xing, Wannan Li
Type 2 diabetes mellitus (T2DM) is marked by persistent hyperglycemia, insulin resistance, and pancreatic β-cell dysfunction, imposing substantial health burdens and elevating the risk of systemic complications and cardiovascular diseases. While the pathogenesis of diabetes remains elusive, a cyclical relationship between insulin resistance and inflammation is acknowledged, wherein inflammation exacerbates insulin resistance, perpetuating a deleterious cycle. Consequently, anti-inflammatory interventions offer a therapeutic avenue for T2DM management...
March 25, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38606899/emerging-drugs-in-phase-ii-and-iii-clinical-development-for-the-treatment-of-alcohol-use-disorder
#5
REVIEW
Sophie Köhne, Thomas Hillemacher, Alexander Glahn, Patrick Bach
INTRODUCTION: Alcohol Use Disorder (AUD) poses an ongoing significant global health burden. AUD is highly prevalent and affects not only the individuals with AUD, but also their communities and society at large. Even though pharmacotherapy is an integral part of AUD treatment, the few available substances show limited efficacy and limited clinical impact. Thus, there is a need for new innovative pharmacotherapeutic approaches. AREAS COVERED: This paper provides a comprehensive review of drugs approved for the treatment of AUD as well as those currently in phase II and III development...
April 12, 2024: Expert Opinion on Emerging Drugs
https://read.qxmd.com/read/38586124/emerging-and-upcoming-therapies-in-insomnia
#6
JOURNAL ARTICLE
Woo-Ju Kim, Ho-Sook Kim
Insomnia, commonly treated with benzodiazepine (BZD) receptor agonists, presents challenges due to associated serious side effects such as abuse and dependence. To address these concerns, many researches have been conducted to develop and advance both pharmacological and non-pharmacological interventions. Dual orexin receptor antagonists (DORAs), which include suvorexant, daridorexant and lemborexant, have recently been approved by United States Food and Drug Administration (US FDA) as a novel pharmacotherapeutic alternative...
March 2024: Translational and clinical pharmacology
https://read.qxmd.com/read/38584085/-concordance-of-medication-prescription-records-in-the-hospitalised-surgical-patient
#7
JOURNAL ARTICLE
O Guillén Martínez, M J Lucas Mayol, M Rodríguez Morote, L Soriano-Irigaray, C Matoses-Chirivella, A Navarro Ruiz
INTRODUCTION: Electronic prescription is the prescription system that allows healthcare professionals to send medication prescriptions directly to community pharmacies and the outpatient unit of Hospital Pharmacy Services for dispensing. However, there is difficulty in obtaining a reliable pharmacotherapeutic history in chronic patients through electronic prescription upon hospital admission as a critical point for adequate treatment adaptation. Therefore, the pharmacist as a member of the multidisciplinary team must ensure, through medication conciliation, an adequate transition of care through the correct management of the treatment that the chronic patient requires during their hospitalization...
April 6, 2024: Journal of Healthcare Quality Research
https://read.qxmd.com/read/38580318/status-epilepticus-an-update-on-pharmacological-management
#8
JOURNAL ARTICLE
Sulaiman Almohaish, Eljim P Tesoro, Gretchen M Brophy
Status epilepticus (SE) is a neurological emergency that requires timely pharmacological therapy to cease seizure activity. The treatment approach varies based on the time and the treatment stage of SE. Benzodiazepines are considered the first-line therapy during the emergent treatment phase of SE. Antiseizure medicines such as phenytoin, valproic acid, and levetiracetam are recommended during the urgent treatment phase. These drugs appear to have a similar safety and efficacy profile, and individualized therapy should be chosen based on patient characteristics...
April 5, 2024: Seminars in Neurology
https://read.qxmd.com/read/38576186/investigating-the-impact-of-psidium-guajava-leaf-hydroalcoholic-extract-in-improving-glutamatergic-toxicity-induced-oxidative-stress-in-danio-rerio-larvae
#9
JOURNAL ARTICLE
Andressa Rubim Lopes, Dennis Guilherme Costa Silva, Nathane Rosa Rodrigues, Illana Kemmerich Martins, Luana Paganotto Leandro, Mauro Eugênio Medina Nunes, Thais Posser, Jeferson Franco
Glutamate is one of the predominant excitatory neurotransmitters released from the central nervous system; however, at high concentrations, this substance may induce excitotoxicity. This phenomenon is involved in numerous neuropathologies. At present, clinically available pharmacotherapeutic agents to counteract glutamatergic excitotoxicity are not completely effective; therefore, research to develop novel compounds is necessary. In this study, the main objective was to determine the pharmacotherapeutic potential of the hydroalcoholic extract of Psidium guajava (PG) in a model of oxidative stress-induced by exposure to glutamate utilizing Danio rerio larvae (zebrafish) as a model...
April 4, 2024: Journal of Toxicology and Environmental Health. Part A
https://read.qxmd.com/read/38575268/trigeminal-and-glossopharyngeal-neuralgia
#10
REVIEW
Anthony K Allam, M Benjamin Larkin, Himanshu Sharma, Ashwin Viswanathan
Trigeminal neuralgia and glossopharyngeal neuralgia are craniofacial pain syndromes characterized by recurrent brief shock-like pains in the distributions of their respective cranial nerves. In this article, the authors aim to summarize each condition's characteristics, pathophysiology, and current pharmacotherapeutic and surgical interventions available for managing and treating these conditions.
May 2024: Neurologic Clinics
https://read.qxmd.com/read/38574932/garcinol-a-novel-and-potent-inhibitor-of-hyaluronidase-enzyme
#11
JOURNAL ARTICLE
R S Thoyajakshi, G T Megha, H Ravi Kumar, Shridhar N Mathad, Anish Khan, S Nagaraju, Mohamed H Mahmoud, AbuZar Ansari
Extracellular matrix (ECM) contains hyaluronic acid (HA) as its integral part that is involved in numerous functional activities within the body. Degradation of HA by hyaluronidase enzyme involved in many pathophysiological conditions such as asthma, arthritis, COPD and in venom spreading during envenomation. Inhibitor of hyaluronidase enzyme has a wide range of application along with the hyaluronan-hyaluronidase system. In this present study, we have evaluated the inhibitory effect of garcinol against hyaluronidase from Hippasa partita spider venom (HPHyal), bovine testicular hyaluronidase (BTH) and human serum hyaluronidase...
April 2, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38574626/biomedicine-and-pharmacotherapeutic-effectiveness-of-combinatorial-atorvastatin-and-quercetin-on-diabetic-nephropathy-an-in-vitro-study
#12
JOURNAL ARTICLE
Haleema Shahin Dh, Rokeya Sultana, Ashwini Prabhu, Pavan S R, Sourav Mohanto, Vetriselvan Subramaniyan
INTRODUCTION: Diabetic nephropathy is a type of kidney disorder that develops as a complication of multifactorial diabetes. Diabetic nephropathy is characterized by microangiopathy, resulting from glucose metabolism, oxidative stress, and changes in renal hemodynamics. This study strived to evaluate the in vitro cytoprotective activity of atorvastatin (ATR), and quercetin (QCT) alone and in combination against diabetic nephropathy. METHODS: The MTT assay was utilized to analyze the effects of the test compounds on NRK-52E rat kidney epithelial cells...
April 3, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38570725/dutch-pharmacogenetics-working-group-dpwg-guideline-for-the-gene-drug-interaction-of-cyp2c9-hla-a-and-hla-b-with-anti-epileptic-drugs
#13
JOURNAL ARTICLE
Lisanne E N Manson, Marga Nijenhuis, Bianca Soree, Nienke J de Boer-Veger, Anne-Marie Buunk, Elisa J F Houwink, Arne Risselada, Gerard A P J M Rongen, Ron H N van Schaik, Jesse J Swen, Daan J Touw, Roos van Westrhenen, Vera H M Deneer, Henk-Jan Guchelaar
By developing evidence-based pharmacogenetics guidelines to optimize pharmacotherapy, the Dutch Pharmacogenetics Working Group (DPWG) aims to advance the implementation of pharmacogenetics (PGx). This guideline outlines the gene-drug interaction of CYP2C9 and HLA-B with phenytoin, HLA-A and HLA-B with carbamazepine and HLA-B with oxcarbazepine and lamotrigine. A systematic review was performed and pharmacotherapeutic recommendations were developed. For CYP2C9 intermediate and poor metabolisers, the DPWG recommends lowering the daily dose of phenytoin and adjust based on effect and serum concentration after 7-10 days...
April 3, 2024: European Journal of Human Genetics: EJHG
https://read.qxmd.com/read/38560605/pharmacotherapeutic-considerations-in-the-treatment-of-nontuberculous-mycobacterial-infections-a-primer-for-clinicians
#14
REVIEW
Christo Cimino, Christina G Rivera, Jeffrey C Pearson, Benjamin Colton, Douglas Slain, Monica V Mahoney
Nontuberculous mycobacteria (NTM) can cause a variety of infections, including serious pulmonary disease. Treatment encompasses polypharmacy, with a targeted regimen of 2-5 active medications, depending on site of infection, species, and clinical characteristics. Medications may include oral, intravenous, and inhalational routes. Medication acquisition can be challenging for numerous reasons, including investigational status, limited distribution models, and insurance prior authorization. Additionally, monitoring and managing adverse reactions and drug interactions is a unique skill set...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38551039/current-concepts-in-the-molecular-mechanisms-and-management-of-diabetic-neuropathy-by-pharmacotherapeutics-and-natural-compounds
#15
JOURNAL ARTICLE
Shivam, Asheesh Kumar Gupta, Sushil Kumar
One of the most crippling effects of diabetes mellitus is diabetic neuropathy, which can cause discomfort, loss of movement, and even amputation. Diabetic neuropathy manifests in a variety of ways, ranging from pain to death. Diagnosing diabetic neuropathy can be challenging since it often goes unnoticed for many years following the onset of diabetes. In addition to oxidative stress in neurons, hyperglycemia activates a number of metabolic pathways that are important sources of damage and possible targets for treatment in diabetic neuropathy...
March 28, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38549577/the-impact-of-apis-dorsata-forest-honey-administration-on-follicle-stimulating-hormone-and-luteinizing-hormone-levels-in-rats-rattus-norvegicus-forced-swim-test-as-a-chronic-physical-animal-model
#16
JOURNAL ARTICLE
Widjiati Widjiati, Epy Muhammad Luqman, Suryo Kuntjorodjakti, Aulanni'am Aulanni'am, Zahra Shabira, Sultan Fadhilla Taqwa, Riski Lesta Mega, Dean Chou, Ahmad Shofy Mubarak, Viski Fitri Hendrawan
BACKGROUND: Chronic physical stress has many effects on the nervous system and can cause structural changes in different parts of the brain and hemomodulatory, including hormonal. Current pharmacotherapeutic treatments have limited efficacy and are associated with many deleterious side effects. AIM: The aim of this research is to determine how Apis dorsata forest honey administration affects follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels in rats who are subjected to forced swim tests as a model of chronic physical stress placed in a container filled with water from which it cannot escape...
February 2024: Open Veterinary Journal
https://read.qxmd.com/read/38543232/categorical-analysis-of-database-consistency-in-reporting-drug-drug-interactions-for-cardiovascular-diseases
#17
JOURNAL ARTICLE
Liana Suciu, Sebastian Mihai Ardelean, Mihai Udrescu, Florina-Diana Goldiş, Daiana Hânda, Maria-Medana Tuică, Sabina-Oana Vasii, Lucreţia Udrescu
Drug-drug interactions (DDIs) can either enhance or diminish the positive or negative effects of the associated drugs. Multiple drug combinations create difficulties in identifying clinically relevant drug interactions; this is why electronic drug interaction checkers frequently report DDI results inconsistently. Our paper aims to analyze drug interactions in cardiovascular diseases by selecting drugs from pharmacotherapeutic subcategories of interest according to Level 2 of the Anatomical Therapeutic Chemical (ATC) classification system...
February 28, 2024: Pharmaceutics
https://read.qxmd.com/read/38542027/cholangiocyte-organoids-the-new-frontier-in-regenerative-medicine-for-the-study-and-treatment-of-cholangiopathies
#18
REVIEW
Serena Babboni, Pier Giuseppe Vacca, Ludovica Simonini, Daniele Pezzati, Caterina Martinelli, Francesco Frongillo, Giuseppe Bianco, Emanuele Marciano, Giuseppina Basta, Davide Ghinolfi, Serena Del Turco
Cholangiopathies include a group of chronic progressive disorders, affecting the cholangiocytes, the epithelial cells that line the biliary tree, leading to liver parenchymal fibrosis and eventually end-stage liver disease necessitating transplantation. Experimental modeling of these multifactorial cholestatic diseases faces challenges due to the lack of adequate experimental in vitro and in vivo models. A novel approach employs three-dimensional organoid systems that offer several advantages for modeling disease and testing drug response in vitro...
March 21, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38541967/evaluation-of-serum-myostatin-concentration-in-chronic-heart-failure-with-preserved-and-impaired-left-ventricular-ejection-fraction
#19
JOURNAL ARTICLE
Jan Bączek, Mirosław Charkiewicz, Agnieszka Kasiukiewicz, Anna Maria Witkowska, Łukasz Magnuszewski, Marta Bączek, Zyta Beata Wojszel
Background: Chronic heart failure (CHF) is a complex clinical syndrome associated with muscle wasting, which can progress to cardiac cachexia. Myostatin, a negative regulator of muscle growth, has been implicated in the pathophysiology of muscle wasting in CHF patients and suggested as a potential biomarker. The objective of this study was to investigate serum myostatin concentration in patients with CHF with preserved and reduced ejection fraction. Methods: The authors conducted a single-centre study comparing serum myostatin levels, functional and echocardiographic parameters, muscle mass, strength and function in patients with CHF to a control group without CHF...
March 18, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38540209/impact-of-pharmacogenetic-testing-on-clozapine-treatment-efficacy-in-patients-with-treatment-resistant-schizophrenia
#20
JOURNAL ARTICLE
Estela Sangüesa, Emilio Fernández-Egea, Julia Concha, Cristina B García, María Pilar Ribate
Managing schizophrenia with clozapine poses a significant challenge due to prevalent therapeutic failures. The increasing interest in personalized medicine underscores the importance of integrating pharmacogenetic information for effective pharmacotherapeutic monitoring in patients. The objective of this study was to explore the correlation between DRD2 , HTR2A , SLC6A4 , CYP1A2 , and ABCB1 polymorphisms and clozapine response in 100 patients with Treatment-Resistant Schizophrenia. Different scales such as the Positive and Negative Syndrome Scale (PANSS), the Warwick-Edinburgh Mental Wellbeing Scale (SWEMWBS), the Global Assessment of Functioning Scale (GAF), the Brief Negative Symptom Scale (BNSS), and pharmacokinetic parameters were used to analyse the efficacy of the treatment...
March 7, 2024: Biomedicines
keyword
keyword
19274
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.